Gemeinschaftspraxis Michael Berse & Hans Schippel
- Address
- Königstraße 49, 47051 Duisburg, Germany
Gemeinschaftspraxis Michael Berse & Hans Schippel - Sleep Medicine Research
Gemeinschaftspraxis Michael Berse & Hans Schippel is a clinical research practice specializing in sleep disorders and their complex interactions with other medical conditions. The center demonstrates particular expertise in evaluating novel therapeutic approaches for patients experiencing multiple concurrent sleep-related symptoms.
- Insomnia disorder treatment and management
- Comorbid sleep and urological conditions
- Novel pharmacological interventions for sleep disturbances
The practice is actively engaged in advancing treatment options for insomnia disorder, with a specific focus on complex cases involving comorbid nocturia. Their research portfolio includes investigating the safety and efficacy of daridorexant, demonstrating their commitment to evaluating innovative therapeutic agents that address the challenging intersection of sleep medicine and urological health in patients with multiple concurrent conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gemeinschaftspraxis Michael Berse & Hans Schippel
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multi-center, double-blind, randomized, placebo-controlled, 2-way cross-over post approval study to investigate the efficacy of daridorexant in subjects with insomnia and comorbid nocturia | Idorsia Pharmaceuticals Ltd. | Phase III | Not Recruiting | Mar 2023 | Apr 2024 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Daridorexant | 1 | Unknown | 2023-03-08 | 2023-03-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.